Caxton Associates (New York)’s RenaissanceRe RNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-2,934
Closed -$541K – 616
2022
Q4
$541K Buy
+2,934
New +$494K 0.04% 223
2020
Q1
– Sell
-1,190
Closed -$233K – 559
2019
Q4
$233K Buy
+1,190
New +$225K 0.03% 330
2019
Q3
– Sell
-20,000
Closed -$3.56M – 523
2019
Q2
$3.56M Sell
20,000
-20,000
-50% -$3.29M 0.43% 42
2019
Q1
$5.74M Buy
+40,000
New +$5.6M 0.83% 33
2017
Q3
– Sell
-5,019
Closed -$698K – 604
2017
Q2
$698K Buy
+5,019
New +$705K 0.03% 222

Other funds holding RNR

Caxton Associates (New York)'s RNR Position: Q1 2023 in Review

Caxton Associates (New York) sold out of RenaissanceRe (RNR) in Q1 2023, closing a stake of 2,934 shares — an estimated $541K sold.

Caxton Associates (New York) first reported a position in RNR in Q2 2017 and held it in 5 quarters. The position peaked at $5.74M in Q1 2019. 381 funds tracked by Wall St. Rank hold RNR as of Q1 2023.

  • Caxton Associates (New York) reported no remaining RenaissanceRe position as of Q1 2023 after selling out during the quarter.
  • Caxton Associates (New York) sold 2,934 RenaissanceRe shares in Q1 2023, an estimated $541K.
  • Caxton Associates (New York) first reported a position in RenaissanceRe in Q2 2017 and held it in 5 quarters.
  • Caxton Associates (New York)'s RenaissanceRe position peaked at $5.74M in Q1 2019.
  • 381 funds tracked by Wall St. Rank held RenaissanceRe as of Q1 2023.

Based on Caxton Associates (New York)'s 13F filing for Q1 2023, filed 15 May 2023.